KEYTRUDA (pembrolizumab), developed by Merck & Co. (MSD), was approved to treat patients with solid tumours that are high microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Previously, the FDA had approved cancer therapies based on where the cancer originated...
72 These data led to the approval of belatacept as an immunosuppressive agent to be used in conjunction with noncalcineurin inhibitor–based treatment regimens in kidney transplant recipients.73 With respect to the PD-1 axis, there is preclinical evidence that manipulation of these pathways can ...
The drugs Yervoy, Keytruda, and Opdivo work by causing the immune system to function more than usual. The unusually named T-VEC, Imlygic is actually a man-made virus that specifically infects cancerous cells rather than normal cells. These drugs are indicated for late-stage melanoma cases, an...
This pharma giant has one of the most successful immunotherapies on the market. Following a big jump in the number of lung cancer patients being tested to see if they would benefit from the treatment, sales are predicted to grow significantly. Keytruda has been approved in testing in some peop...
Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well?Continue reading
This pharma giant has one of the most successful immunotherapies on the market. Following a big jump in the number of lung cancer patients being tested to see if they would benefit from the treatment, sales are predicted to grow significantly. Keytruda has been approved in testing in some peop...